A Pilot Study for the Efficacy and Safety of Mesenchymal Stem Cell in Acute Severe Respiratory Failure.
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Autologous mesenchymal stem cell therapy Pharmicell (Primary)
- Indications Adult respiratory distress syndrome
- Focus Therapeutic Use
- Acronyms STELLAR
Most Recent Events
- 17 Feb 2016 New trial record